Drug discovery and biotechnology are multi-objective optimisation challenges. Machine learning models integrate well into an enzyme engineering pipeline to predict properties and functions. Parallelising these models allows multi-objective optimisation.
Comments
https://www.biorxiv.org/content/10.1101/2025.01.18.633707v1.full.pdf
Visit http://ingeniebio.com and let's talk.